Ohlstein EH - Search Results

1

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.

Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Circ Res. 1994 Jul;75(1):190-7. doi: 10.1161/01.res.75.1.190. Circ Res. 1994. PMID: 8013078

2

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.

Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. Ohlstein EH, et al. Eur J Pharmacol. 1992 Apr 10;225(4):347-50. doi: 10.1016/0922-4106(92)90109-9. Eur J Pharmacol. 1992. PMID: 1323478

3

Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responses.

Douglas SA, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Eur J Pharmacol. 1992 Oct 20;221(2-3):315-24. doi: 10.1016/0014-2999(92)90718-j. Eur J Pharmacol. 1992. PMID: 1426008

4

Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells.

Ohlstein EH, Storer BL, Butcher JA, Debouck C, Feuerstein G. Ohlstein EH, et al. Circ Res. 1991 Sep;69(3):832-41. doi: 10.1161/01.res.69.3.832. Circ Res. 1991. PMID: 1873876

5

Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.

Ohlstein EH, Douglas SA, Ezekiel M, Gellai M. Ohlstein EH, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S321-4. doi: 10.1097/00005344-199322008-00084. J Cardiovasc Pharmacol. 1993. PMID: 7509976

6

Endothelin-1 promotes neointima formation after balloon angioplasty in the rat.

Douglas SA, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S371-3. doi: 10.1097/00005344-199322008-00097. J Cardiovasc Pharmacol. 1993. PMID: 7509990

7

Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction.

Douglas SA, Vickery-Clark LM, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Eur J Pharmacol. 1994 Apr 1;255(1-3):81-9. doi: 10.1016/0014-2999(94)90085-x. Eur J Pharmacol. 1994. PMID: 7517884

8

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP. Gellai M, et al. Among authors: ohlstein eh. J Pharmacol Exp Ther. 1995 Oct;275(1):200-6. J Pharmacol Exp Ther. 1995. PMID: 7562550

9

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein.

Douglas SA, Beck GR Jr, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Br J Pharmacol. 1995 Apr;114(8):1529-40. doi: 10.1111/j.1476-5381.1995.tb14936.x. Br J Pharmacol. 1995. PMID: 7599920 Free PMC article.

10

Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat.

Douglas SA, Vickery-Clark LM, Louden C, Ohlstein EH. Douglas SA, et al. Among authors: ohlstein eh. Cardiovasc Res. 1995 May;29(5):641-6. Cardiovasc Res. 1995. PMID: 7606751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters